RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin22.320
K Miyaji, M Suzuki, R Watanabe, K Matoba, A Nakazono, Y Nakamaru, K Ebina, T Abe, D Hinder, A J Psaltis, P J Wormald, A Homma, A Konno
{"title":"Motion analysis for objective evaluation of psychomotor skills in Endoscopic Sinus Surgery.","authors":"K Miyaji, M Suzuki, R Watanabe, K Matoba, A Nakazono, Y Nakamaru, K Ebina, T Abe, D Hinder, A J Psaltis, P J Wormald, A Homma, A Konno","doi":"10.4193/Rhin22.320","DOIUrl":"10.4193/Rhin22.320","url":null,"abstract":"<p><strong>Background: </strong>This study aims to digitalize surgical maneuvers in ESS using a motion capture system under standardized conditions provided by 3D printed-sinus models.</p><p><strong>Methodology: </strong>Forty-seven otolaryngologists performed ESS on 3D printed models manufactured from computed tomography (CT) images of actual patients. Participants were classified to 3 groups according to the objective structured technical skills assessment score. All surgical maneuverers performed during ESS were captured by a motion capture system. The path length, velocity, acceleration, and jerk were calculated for each surgical instrument and compared among the groups. Principle Component Analysis (PCA) was utilized to identify which metrics reflected surgical skill level. In addition, ten registrars repeated the surgical dissection. Their motion metrics were also compared between first training and the repeated training and then subjected to the PCA.</p><p><strong>Results: </strong>Several metrics such as the angular acceleration and jerk of the cutting forceps were identified by PCA as possible indicators distinguishing the different skill levels for the ESS maneuvers. PCA analysis in the repetitive training also found the angular metrics of the upturned-cutting forceps correlating to their skill improvement.</p><p><strong>Conclusions: </strong>Combined with the validated 3D-printed sinus models, the motion capture system provided the objective evaluation of the surgical performances of ESS.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"190-199"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142903533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.443
S P Williams, S C Leong
{"title":"Validation of the Sino-Nasal Outcome Test-25 (SNOT-25) measure for patients with nasal septal perforation.","authors":"S P Williams, S C Leong","doi":"10.4193/Rhin24.443","DOIUrl":"10.4193/Rhin24.443","url":null,"abstract":"<p><p>Nasal septal perforations (NSPs) are a common referral to specialist rhinology practice. A wide range of management options have been described but to be able to offer the most effective treatment modalities to our patients we must be able to capture quantitative data on patient symptom burden accurately and robustly.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"248-249"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143041208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.457
P W Hellings, E De Corso, V Backer, M Bernal-Sprekelsen, Y Chan, D M Conti, M E Cornet, W J Fokkens, P Gevaert, J Han, C Hopkins, B N Landis, S Lau, S Lee, V J Lund, J Mullol, A Peters, S Schneider, B Senior
{"title":"Remission in chronic rhinosinusitis with nasal polyps (CRSwNP).","authors":"P W Hellings, E De Corso, V Backer, M Bernal-Sprekelsen, Y Chan, D M Conti, M E Cornet, W J Fokkens, P Gevaert, J Han, C Hopkins, B N Landis, S Lau, S Lee, V J Lund, J Mullol, A Peters, S Schneider, B Senior","doi":"10.4193/Rhin24.457","DOIUrl":"10.4193/Rhin24.457","url":null,"abstract":"<p><p>Remission has recently been proposed as the new goal of care in CRSwNP or Nasal Polyp Syndrome by the European Forum for Research and Education in Allergy and Airway Diseases / European Position Paper on Rhinosinusitis and Nasal Polyps (EUFOREA/EPOS) (1,2) as well as by global leaders in Rhinology (3). In CRSwNP, remission is defined as a prolonged state of control, without bothersome symptoms reported by the patient for at least 12 months, without the need for either oral corticosteroids or endoscopic sinus surgery (ESS), and without endoscopic signs of active disease (1). This new goal of care is to be encouraged by the ENT community and CRSwNP patients as persistent symptoms unalleviated by historical approaches (4,5) can be reduced by new therapies including biologics. The goal of therapy for CRSwNP has long been to achieve control, with Visual Analogue Scale (VAS) and Sino-Nasal Outcome Test (SNOT-22) scores guiding physicians towards a step-up treatment aiming for control (6,7).</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"239-241"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143468909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.475
J Sutphin, S Okafor, S D Reed, A Deb, J Silver, M J Wallace, J-C Yang, R Abi Hachem, D W Jang
{"title":"Patient preferences for treatment of chronic rhinosinusitis with nasal polyps.","authors":"J Sutphin, S Okafor, S D Reed, A Deb, J Silver, M J Wallace, J-C Yang, R Abi Hachem, D W Jang","doi":"10.4193/Rhin24.475","DOIUrl":"10.4193/Rhin24.475","url":null,"abstract":"<p><p>Choosing between revision endoscopic sinus surgery (ESS) versus biologic therapy for recurrent chronic rhinosinusitis with nasal polyposis (CRSwNP) is a complex, multifaceted decision that involves not only clinical and financial factors but also patient preferences. Currently, there are no quantitative studies investigating patient preferences for CRSwNP treatment options. Increased awareness of patient-centered approaches to treatment warrant further investigation.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"245-247"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142979886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.165
V Rampinelli, M Ferrari, I Dohin, A Vinciguerra, D Mattavelli, T Saccardo, G Testa, C Conti, C Frigerio, B Verillaud, G Ajasllari, P Gaudioso, D Cazzador, A Aga, S Taboni, A Daniele Arioso, L Neri, D Borsetto, A Wolf, C Rodriguez-Van Strahlen, M Turri-Zanoni, E Emanuelli, A Schreiber, P Battaglia, F Pagella, M Bignami, C Piazza, P Castelnuovo, P Nicolai, P Herman
{"title":"Advanced paranasal sinuses osteomas: a retrospective multicentric analysis on surgical management outcomes and intra- and postsurgical complications.","authors":"V Rampinelli, M Ferrari, I Dohin, A Vinciguerra, D Mattavelli, T Saccardo, G Testa, C Conti, C Frigerio, B Verillaud, G Ajasllari, P Gaudioso, D Cazzador, A Aga, S Taboni, A Daniele Arioso, L Neri, D Borsetto, A Wolf, C Rodriguez-Van Strahlen, M Turri-Zanoni, E Emanuelli, A Schreiber, P Battaglia, F Pagella, M Bignami, C Piazza, P Castelnuovo, P Nicolai, P Herman","doi":"10.4193/Rhin24.165","DOIUrl":"10.4193/Rhin24.165","url":null,"abstract":"<p><strong>Background: </strong>This study examines the management and outcomes of large paranasal sinus osteomas (PSO), especially those abutting or encasing critical structures of the skull base and orbit.</p><p><strong>Methodology: </strong>A multicentric retrospective analysis was conducted between June 2007 and September 2023. The study included surgically treated (regardless the type of approach chosen) PSO, exceeding 3 cm in diameter and/or located in critical anatomical areas. An analysis was performed to assess the association between the critical relationships, size, presence of residual disease, and incidence of intra- and postoperative complications.</p><p><strong>Results: </strong>The series included 160 patients. Most PSO were diagnosed due to clinical symptoms, predominantly for those located in the frontal sinus. Residual disease was observed in 9.4% of patients, with its occurrence influenced by PSO size and relationships with specific anatomical structures. Thirty-five/160 (21.9%) of patients experienced one or more intra-and/or postoperative complications. Intraoperative complications were associated with the proximity of PSO to the cribriform plate. Long-term complications were more frequently observed in cases involving the anterior and posterior plate of the frontal bone.</p><p><strong>Conclusions: </strong>This study highlights the complexities involved in managing large PSO, demonstrating that size and anatomical relationships of these osteomas can critically influence surgical decisions, residual disease, and complication rate. The study's retrospective design limited the collection of standardized symptom outcomes, highlighting the need for future studies to address this apect.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"209-220"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.379
E Granell, A Cardesin, D Pallares, R Sanchez, J R Gras
{"title":"Radial intralesional linear calcifications and focal hyperostosis: key points for diagnosis, extension and point of origin identification of sinonasal inverted papilloma.","authors":"E Granell, A Cardesin, D Pallares, R Sanchez, J R Gras","doi":"10.4193/Rhin24.379","DOIUrl":"10.4193/Rhin24.379","url":null,"abstract":"<p><p>Sinonasal inverted papilloma (IP) often appears as a unilateral sinonasal soft-tissue mass with varying enhancement, often accompanied by bone remodelling, intralesional calcifications, focal hyperostosis, and cone-shaped bone thickening (observed in 60 to 80% of cases) (1,2). A non-contrast sinonasal CT scan may reveal a soft tissue polypoid mass that closely resembles inflammatory polyps (Figure 1 A-D). While hyperostosis is recognized as a marker of the tumor's point of origin (1), intralesional calcifications are less frequently described but may offer valuable insights. Early studies, such as those by Lund and Lloyd (1984), highlighted the presence of intralesional calcifications as a distinct feature of inverted papilloma, a finding later supported by studies emphasizing the role of bone morphogenic proteins in calcification development (4-7).</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"250-252"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.510
W J Fokkens, V Backer, V J Lund, P J Barnes, M Bernal-Sprekelsen, L Bjermer, E de Corso, D M Conti, M E Cornet, Z Diamant, R Djukanovic, M Gaga, P Gevaert, J K Han, C Hopkins, G Joos, B N Landis, S Lau, S E Lee, J Mullol, A T Peters, G K Scadding, S Schneider, B Senior, I D Pavord, S Quirce, D Ryan, M E Wechsler, P W Hellings
{"title":"Pocket guide: biologics in upper and lower airways in adults.","authors":"W J Fokkens, V Backer, V J Lund, P J Barnes, M Bernal-Sprekelsen, L Bjermer, E de Corso, D M Conti, M E Cornet, Z Diamant, R Djukanovic, M Gaga, P Gevaert, J K Han, C Hopkins, G Joos, B N Landis, S Lau, S E Lee, J Mullol, A T Peters, G K Scadding, S Schneider, B Senior, I D Pavord, S Quirce, D Ryan, M E Wechsler, P W Hellings","doi":"10.4193/Rhin24.510","DOIUrl":"10.4193/Rhin24.510","url":null,"abstract":"<p><p>The introduction of biologics for the treatment of severe upper and lower (type 2) airway inflammation has been a game changer in the management of these diseases. Biologics are injectable medications targeting different molecules relevant in (type 2) inflammation in patients with severe (type 2) airway diseases, like asthma, eosinophilic chronic obstructive pulmonary disease (COPD), chronic rhinosinusitis (CRS) and those who remain uncontrolled despite regular treatment. After the phase 3 trials, showing significant impact on symptoms, quality of life and interventions like surgery (for the upper airways) and exacerbations needing hospitalisation (for the lower airways), biologics are now used in daily practice in many parts of the world. This pocket guide is aimed at all specialists treating adult patients with severe airway disease.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"242-244"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143557853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.421
M Lazzeroni, H Elzinga, P Merkus, E van Spronsen, W J Fokkens, S Reitsma
{"title":"Management of eosinophilic otitis media in the era of biological therapy: systematic review and proportion meta-analysis.","authors":"M Lazzeroni, H Elzinga, P Merkus, E van Spronsen, W J Fokkens, S Reitsma","doi":"10.4193/Rhin24.421","DOIUrl":"10.4193/Rhin24.421","url":null,"abstract":"<p><strong>Background: </strong>Eosinophilic otitis media (EOM) is a recently recognised type 2 inflammatory disease, strongly associated with asthma and chronic rhinosinusitis with nasal polyps. Known as a difficult-to-treat condition, EOM is often refractory to traditional therapies for (chronic) otitis media. This review aims to assess the success rates of the different interventions for patients with EOM including newly available biological therapy.</p><p><strong>Methodology: </strong>In March 2024 we systematically searched PubMed, Embase, Scopus and Web of Science for studies on more than 5 EOM patients undergoing any medical or surgical intervention with a reported success rate. Proportion meta-analysis on a random effect model was used to synthesize results effectively. Risk of bias was assessed through the Risk Of Bias In Non randomized Studies of Interventions tool (ROBINS-I).</p><p><strong>Results: </strong>From 1103 potential articles, 14 studies with 361 patients were included. 62% were females and 85% had bilateral presentation. Otorrhoea was present in 68% of patients, tympanic membrane perforation in 50%. The overall success rate was 61.3. However, interventions comprising biological agents targeting type 2 inflammatory cascade showed higher success rates compared to non-biological treatments.</p><p><strong>Conclusions: </strong>A shift towards biologic-based therapies could be beneficial for managing the challenging condition EOM.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"145-152"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142903532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin23.501
T Yang, C Liu, Y Wang, J Zhou, Y Li, H Wei
{"title":"Analysis of clinical characteristics of fungus ball based on the number of involved sinuses.","authors":"T Yang, C Liu, Y Wang, J Zhou, Y Li, H Wei","doi":"10.4193/Rhin23.501","DOIUrl":"10.4193/Rhin23.501","url":null,"abstract":"<p><strong>Background: </strong>Fungus ball (FB) typically presents unilaterally, with the maxillary sinus being the most commonly affected site.Multi-sinus FB cases are seldom discussed.</p><p><strong>Methodology: </strong>A retrospective study involving 1709 FB patients categorized them into single sinus fungus ball (SSFB), double sinus fungus balls (DSFB), and multiple sinus fungus balls (MSFB) groups for clinical analysis.</p><p><strong>Results: </strong>The SSFB group comprised 1596 patients (93.39%), the DSFB group 111 patients (6.50%), and the MSFB group two patients (0.12%). The prevalence of diabetes mellitus in the DSFB group was higher than that in the SSFB group. A female prevalence was noticed and there was no difference in the sex ratio by age group. On computed tomography (CT), maxillary sinus FB group had higher intralesional hyperdensity than sphenoid sinus FB group. Oppositely, sphenoid sinus FB group had higher lateral sinus wall sclerosis than maxillary sinus FB group.</p><p><strong>Conclusions: </strong>DSFB occurs in a minority of cases but needs to be investigated especially in diabetics given the link between diabetes mellitus and increased DSFB risk. A female predominance is seen in both pre- and postmenopausal women. On CT, the presence of intralesional hyperdensity and lateral sinus wall sclerosis correlates with the location of the FB.</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"230-236"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143468908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RhinologyPub Date : 2025-04-01DOI: 10.4193/Rhin24.317
A Vinciguerra, A Daloiso, I Dohin, F Boaria, M Marc, M Ferrari, B Verillaud, F Chatelet, P Herman
{"title":"Ligation of anterior ethmoidal artery nasal branch: anatomical-based management of recalcitrant epistaxis.","authors":"A Vinciguerra, A Daloiso, I Dohin, F Boaria, M Marc, M Ferrari, B Verillaud, F Chatelet, P Herman","doi":"10.4193/Rhin24.317","DOIUrl":"10.4193/Rhin24.317","url":null,"abstract":"<p><p>Recurrent epistaxis, despite conservative therapies (i.e. nasal packing or direct vessel coagulation), is generally treated with ligation of the sphenopalatine artery (SPA). Indeed, the rationale behind SPA ligation lies in its ability to disrupt arterial blood supply to the nasal mucosa, thereby reducing the likelihood of recurrent bleeding episodes (1). Nevertheless, in some cases, nosebleeds persist despite appropriate SPA ligation, opening discussion of the anterior ethmoidal artery (AEA) contribution in recalcitrant epistaxis that, for some authors, is up to 28.8% (2). From an anatomical point of view, the AEA leaves the orbital cavity and passes the ethmoidal roof through the ethmoidal canal, before entering inside the anterior cranial fossa via the lateral lamella (3). Endocranially, the AEA gives posterior branches which vascularize the anterior cribriform plate, whereas its many trunk continues anteriorly and divides into two branches: the anterior meningeal branch, and a second vessel that enters inside the nasal fossa through the cribroethmoidal foramen located 2.86 ± 1.93 mm (range, 1-7 mm) (4) anteriorly to the first olfactory phylum, giving rise to the so-called nasal branch (NbAEA) (5).</p>","PeriodicalId":21361,"journal":{"name":"Rhinology","volume":" ","pages":"253-255"},"PeriodicalIF":4.8,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}